Phase II Trial of Neoadjuvant Exemestane in Combination With Celecoxib in Postmenopausal Women Who Have Breast Cancer

PURPOSE: Within breast tissue, aromatase expression and activity is increased by prostaglandin E2, providing a rationale for combining the COX-2 inhibitor celecoxib with an aromatase inhibitor. To evaluate the effect of these drugs on aromatase and other biomarkers, a phase II trial of neoadjuvant e...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Lustberg, Maryam B., Povoski, Stephen P., Zhao, Weiqiang, Ziegler, Rebecca M., Sugimoto, Yasuro, Ruppert, Amy S., Lehman, Amy M., Shiels, Donna R., Mrozek, Ewa, Ramaswamy, Bhuvaneswari, Layman, Rachel M., Brueggemeier, Robert W., Shapiro, Charles L.
Формат: Artigo
Язык:Inglês
Опубликовано: 2011
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3440773/
https://ncbi.nlm.nih.gov/pubmed/21729671
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clbc.2011.03.022
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы